# |
PMID |
Sentence |
1 |
9250801
|
Six months after vaccination GMT for neuraminidase 1 (N1) increased when compared with the second sampling; for neuraminidase 2 (N2) and neuraminidase B (NB) it was slightly lower.
|
2 |
22403397
|
NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not.
|
3 |
22403397
|
Using real time RT-PCR to detect mRNAs for the four known mammalian sialidases, NEU1, -2, -3, and -4, NEU1 mRNA was expressed at levels 2700-fold higher that those found for NEU2, -3, or -4.
|
4 |
22403397
|
Western analyses indicated NEU1 and -3 protein expression.
|
5 |
22403397
|
Prior siRNA-mediated knockdown of NEU1 and NEU3 each decreased EC sialidase activity for 4-MU-NANA by >65 and >17%, respectively, and for the ganglioside mixture by 0 and 40%, respectively.
|
6 |
22403397
|
NEU1 overexpression in ECs reduced their migration into a wound by >40%, whereas NEU3 overexpression did not.
|
7 |
22403397
|
Immunohistochemical studies of normal human tissues immunolocalized NEU1 and NEU3 proteins to both pulmonary and extrapulmonary vascular endothelia.
|
8 |
22403397
|
These combined data indicate that human lung microvascular ECs as well as other endothelia express catalytically active NEU1 and NEU3.
|
9 |
22403397
|
NEU1 restrains EC migration, whereas NEU3 does not.
|